For more than a decade, we have framed real-world evidence (RWE) challenges as a data problem. Not enough access. Not enough scale. Not enough linkage. Not enough quality. However, this narrative has become increasingly difficult to sustain. Across major markets, data availability has expanded, platforms have matured, and analytical methods have become more standardized and… Continue reading The RWE Paradox: Plenty of Data, Fragile Structure
Tag: Real World Evidence
The Health Data Lab in Germany: A Country Initiative with a Central Role in Health Data Science
What the Health Data Lab Is and How It Works In recent years, Germany has taken important steps toward building a national infrastructure for health data that can support research, planning, and policy. One of the most ambitious initiatives in this direction is the Health Data Lab (Gesundheitsdatenlabor, HDL), managed by the Federal Institute… Continue reading The Health Data Lab in Germany: A Country Initiative with a Central Role in Health Data Science
When Real-World Data Aren’t So “Real” Anymore
As a data-driven endurance athlete, I use several devices to track my performance and progress. Like many others, I occasionally end up in troubleshooting communities (especially those dedicated to Garmin products) trying to understand why a metric looks off or how to recalibrate a sensor. It’s really fascinating to read the discussions. You quickly… Continue reading When Real-World Data Aren’t So “Real” Anymore
Conducting Real-World Evidence (RWE) Studies in Obesity: Opportunities and Challenges
By Patrick Wulf Hanson (Reviewed, adjusted and approved by Dr. Frederik Persson, Head of Clinic, Steno Diabetes Center, Copenhagen, Denmark) 1. Introduction Globally, obesity has emerged as a critical public health challenge, contributing to substantial morbidity and mortality, and it is a leading risk factor for diseases such as type 2 diabetes, cardiometabolic… Continue reading Conducting Real-World Evidence (RWE) Studies in Obesity: Opportunities and Challenges
Internal Data Platforms and Federated Data Models: Understanding the Difference
In the pharmaceutical industry, data has become a strategic asset. Companies are increasingly investing in technologies that enable them to manage, analyze, and derive insights from the enormous amounts of information they generate. As a data strategist, a frequent question I receive is how to build a platform that supports research, monitoring, and evidence generation… Continue reading Internal Data Platforms and Federated Data Models: Understanding the Difference